+91-8668442535

Preventive Healthcare Technologies, Products And Services Market By Type (Early Detection And Screening Technologies, Vaccines, Chronic Disease Management Technologies, Advanced Technologies To Reduce Errors) - Growth, Future Prospects, And Competitive Analysis, 2017 - 2025

Government health departments worldwide are actively seeking to achieve the welfare of the people and society by primarily focusing on extending life expectancy, improving quality of life, providing free distribution of medications, and so on. The rising prevalence of chronic diseases and the corresponding increase in drug discovery and development studies performed by major pharmaceutical manufacturers and research organizations are driving the market for preventive healthcare technologies, products, and services. Additionally, the stringent regulatory norms stipulated by the healthcare agencies have made it mandatory to lay emphasis on early screening and detection of drug molecules that have recently cleared preclinical trials and those set to enter clinical trial studies. The limiting factors related to this market are volatility in the economic performance of pharmaceutical companies, resulting in setbacks to their research and development initiatives actively involved in drug screening, and a lack of expertise in patient engagement activities by healthcare professionals.

The scope of the report comprises preventive healthcare solutions such as early detection and screening technologies, vaccines, advanced technologies to reduce errors, and chronic disease management technologies. The early detection and screening technologies segment is categorized as personalized medicine, automated screening, and other advanced screening technologies. The vaccines segment comprises vaccines for disease areas such as allergies, infectious diseases, cancer, autism, and others. Chronic disease management technologies include cardiovascular monitors, blood pressure monitors, asthma monitors, and glucose monitors. The advanced technologies to reduce errors segment is further categorized into electronic prescribing, computerized provider order entry systems, smart infusion pumps, clinical decision support systems, smart packaging, and automated prescription formulation and dispensing. Comprehensive business analysis in terms of market size and determining market trends is done for such segments for the period 2015–2025.

A description of the market estimation of the above-mentioned segment for the duration of 2015–2025 is covered in the scope of the report, along with the individual market estimations for the respective countries in the regional segments.

A comprehensive study has also been presented in the report scope regarding the market dynamics that revolve around the global market for preventive healthcare technologies, products, and services. A brief understanding of the competition prevalent among the key players related to preventive healthcare, products, and services has been discussed with the provision of a competitive landscape. Porter's five forces model has been included to understand the business environment of the market. The major players in the global preventive healthcare technologies, products, and services market are Alere, Inc., GlaxoSmithKline Plc, Healthways, Inc., McKesson Corporation, Medtronic Plc, Merck & Co., Inc., Pfizer, Inc., Omnicell, Inc., and Scripto LLC.

Based on the types, the global market for preventive healthcare technologies, products, and services is categorized into:

  • Early Detection and Screening Technologies
    • Automated Screening
    • Personalized Medicine
    • Other Advanced Screening Technologies
  • Vaccines
    • Infectious Diseases
    • Autism
    • Allergy
    • Cancer
    • Other Vaccines
  • Chronic Disease Management Technologies
    • Blood pressure monitors
    • Asthma Monitors
    • Cardiovascular Monitors
    • Glucose Monitors
  • Advanced Technologies to Reduce Errors
    • Electronic Prescribing
    • Clinical Decision Support Systems
    • Smart Infusion Pumps
    • Computerized Provider Order Entry Systems
    • Smart packaging and automated prescription formulation and dispensing

The market for preventive healthcare technologies, products, and services is driven by key factors such as the rising prevalence of chronic diseases and enhanced government spending on research and development in the pharmaceutical and biotechnology industries. Additionally, increasing public health awareness and tremendous demand for personalized medications will result in deep market penetration of preventive healthcare technologies, products, and services. At present, early detection and screening technologies hold the largest market share due to key drivers such as increasing drug discovery and development studies being performed for the launch of novel drug formulations and technological advancement in the pharmacogenomics segment resulting in rising demand for personalized medications.

Personalized medicine will also be the fastest-growing sub-segment in the early detection and screening technologies market. Advanced technologies to reduce errors show a promising sales forecast and will be the fastest-growing market, mostly due to factors such as stringent regulatory guidelines to implement and execute cGMP and cGLP guidelines during production activities to achieve flawless results in product quality assurance and validation. Smart packaging and automated prescription formulation and dispensing have gained importance due to the increase in incidents reporting drug-related adverse events with respect to product safety and drug dosage. The major players in the market for preventive healthcare technologies, products, and services are Alere, Inc., GlaxoSmithKline Plc, Healthways, Inc., McKesson Corporation, Medtronic Plc, Merck & Co., Inc., Pfizer, Inc., Omnicell, Inc., and Scripto LLC.

For the purpose of this study, the global market for preventive healthcare technologies, products, and services is categorized into the following regional and country-specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of the Middle East and Africa

In 2016, North America was found to be the largest market for preventive healthcare technologies, products, and services. North America dominated the global market as the region is driven by key factors such as the rising prevalence of chronic diseases, the proactive role played by government healthcare agencies to promote drug discovery and development, and the domicile of major players engaged in the manufacturing of preventive healthcare technologies, products, and services. The market growth in Europe is mainly attributed to an increase in the strategic partnership between research, academia, and the healthcare segment. Asia Pacific is estimated to be the fastest-growing regional segment through the forecast period of 2017–2025.

Factors that are anticipated to propel market growth in Asia-Pacific are a large patient pool with several health complications that require immediate medical consultation and treatment. Enhanced government health department spending to harness the performance of R&D activities for the launch of novel vaccines and a competitive market is due to the presence of existing and budding market players involved in the provision of preventive healthcare technologies, products, and services. Moreover, factors such as the inclination to maintain a healthier lifestyle and health awareness campaigns by major pharma companies regarding contagious diseases and their prevention are also going to fuel the rapid growth of the preventive healthcare technologies, products, and services market in Latin America, the Middle East, and Africa in the near future.

Frequently Asked Questions:

The market for Preventive Healthcare Technologies, Products And Services Market is expected to reach US$ 487.4 Bn By 2025.

The Preventive Healthcare Technologies, Products And Services Market is expected to see significant CAGR growth over the coming years, at 10.99%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Alere, Inc., GlaxoSmithKline Plc, Healthways, Inc., McKesson Corporation, Medtronic Plc, Merck & Co., Inc., Pfizer, Inc., Omnicell, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2017
Category:  Pharmaceuticals
Report ID:   58810
Report Format:   PDF
Pages:   120
Rating:    4.8 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support